KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 1 filers reported holding KALA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,000 | -33.3% | 20,286 | 0.0% | 0.00% | – |
Q2 2022 | $6,000 | -79.3% | 20,286 | -3.3% | 0.00% | -100.0% |
Q1 2022 | $29,000 | -17.1% | 20,986 | -27.9% | 0.00% | -50.0% |
Q4 2021 | $35,000 | -57.3% | 29,126 | -7.2% | 0.00% | -50.0% |
Q3 2021 | $82,000 | -71.8% | 31,376 | -42.8% | 0.00% | -71.4% |
Q2 2021 | $291,000 | -21.4% | 54,876 | +0.1% | 0.01% | -30.0% |
Q1 2021 | $370,000 | +141.8% | 54,845 | +142.9% | 0.02% | +53.8% |
Q4 2020 | $153,000 | -88.4% | 22,580 | -87.1% | 0.01% | -89.7% |
Q3 2020 | $1,315,000 | +16.4% | 175,305 | +63.0% | 0.13% | +17.8% |
Q2 2020 | $1,130,000 | +12.5% | 107,534 | -5.9% | 0.11% | -10.1% |
Q1 2020 | $1,004,000 | +73.7% | 114,253 | -27.0% | 0.12% | +133.3% |
Q4 2019 | $578,000 | +70.0% | 156,534 | +75.4% | 0.05% | +54.5% |
Q3 2019 | $340,000 | +57.4% | 89,225 | +163.9% | 0.03% | +50.0% |
Q2 2019 | $216,000 | -77.7% | 33,815 | -71.1% | 0.02% | -78.8% |
Q1 2019 | $969,000 | +64.5% | 117,129 | -2.8% | 0.10% | +38.7% |
Q4 2018 | $589,000 | -48.5% | 120,509 | +4.0% | 0.08% | -42.3% |
Q3 2018 | $1,143,000 | +47.5% | 115,819 | +105.3% | 0.13% | +35.4% |
Q2 2018 | $775,000 | +57.5% | 56,420 | +81.6% | 0.10% | +50.0% |
Q1 2018 | $492,000 | -5.2% | 31,070 | +10.7% | 0.06% | +1.6% |
Q4 2017 | $519,000 | – | 28,070 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parallel Advisors, LLC | 1 | $9 | 0.00% |